About Impel Pharmaceuticals, Inc. 
Impel Pharmaceuticals, Inc.
Pharmaceuticals: Major
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Strategic Entities
Domestic Funds
Held in 13 Schemes (4.9%)
Foreign Institutions
Held by 14 Foreign Institutions (0.2%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
5 Million
(Quarterly Results - Sep 2023)
Net Profit:
-14 Million
Pharmaceuticals: Major
USD 0 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.17
68.81%
-0.00






